Contraception in the adolescent: An update

Pediatrics

Volumn 107, Issue 3, 2001, Pages 562-573

  Greydanus, Donald E ^a,c   Patel, Dilip R ^a   Rimsza, Mary Ellen ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; COPPER INTRAUTERINE DEVICE; DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ERYTHROMYCIN; ESTROGEN; ETHINYLESTRADIOL PLUS ETYNODIOL DIACETATE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; ETHINYLESTRADIOL PLUS NORGESTREL; GESTAGEN; GRISEOFULVIN; JENEST; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MESTRANOL; MESTRANOL PLUS NORETHISTERONE; METRONIDAZOLE; NORETHISTERONE; NORGESTIMATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; POLYURETHAN; PROGESTERONE; RIFAMPICIN; SPERMICIDAL AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ABORTION; ADOLESCENT; ADOLESCENT PREGNANCY; BLEEDING; CANCER; CONDOM; CONTRACEPTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTRAUTERINE CONTRACEPTIVE DEVICE; MIGRAINE; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

ADOLESCENT; CONTRACEPTION; CONTRACEPTIVE AGENTS; FEMALE; HUMANS; PREGNANCY; PREGNANCY IN ADOLESCENCE;

EID: 0035128339     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.107.3.562     Document Type: Review

References (91)

1. Sexually transmitted diseases, unintended pregnancy, and adolescent health promotion
2. Contraception in the adolescent: Current concepts for the pediatrician
3. Contraception for adolescents: Parts I and II. Adolescent Health Update
4. The power of the pill
5. Providing effective reproductive health care and prescribing contraceptives for adolescents
6. American College of Obstetrics and Gynecology. Safety of oral contraceptives for teenagers
7. Contraception in the adolescent. Preparation for the 1990s
8. Abstinence and safer sex: HIV interventions for African Americans
9. Evaluation of a new generation of oral contraceptives
10. An update for contraception for adolescents
11. Sexual health contraceptive needs of adolescents with chronic conditions
12. Oral contraceptives and cardiovascular events: Summary and application of data
13. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States
14. Effect of different progestagens in low estrogen oral contraceptives on venous thromboembolic disease
15. Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study
16. Enhancement of factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third- generation progestagen
17. The Nurses Health Study: 20-year contribution to the understanding of health among women
18. Hormonal contraception
19. Contraception for women with diabetes
20. Contraception
21. Use of oral contraceptives by women with epilepsy
22. Should adolescents have over-the-counter access to oral contraceptive pills and antibiotics?
23. A practical approach to antibiotic treatment in women taking oral contraceptives
24. Oral contraceptives and noncontraceptive benefits: Summary and application of data
25. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data of 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
26. Oral contraceptives and breast cancer risk: Summary and application of data
27. Contraception
28. Combined oral contraceptives and risk of cervical carcinoma in situ
29. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized placebo controlled trial
30. The health benefits and noncontraceptive uses of oral contraceptives. Adolescent Health Update
31. Benefits and risks of oral contraceptives
32. Health benefits of oral contraceptives; emergency contraception options
33. Contraception
34. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives
35. Adolescents' compliance with the use of oral contraceptives
36. Compliance, counseling and satisfaction with oral contraceptives: A prospective evaluation
37. Progestin-only contraception: A comprehensive review
38. Emergency contraceptives
39. Self-administered emergency contraception-a second chance
40. The effect of self-administered emergency contraception
41. Emergency contraception: A national survey of adolescent health experts
42. New contraceptive options for adolescents
43. An emergency contraceptive kit
44. Mifepristone (RU 486) compared with high dose estrogen and progestogen for emergency postcoital contraception
45. Contraceptive efficacy, of the diaphragm, the sponge, and the cervical cap
46. Future barrier methods
47. Contraceptive efficacy and acceptability of the female condom
48. Guidelines for Treatment of Sexually Transmitted Diseases
49. The use of nonoxynol-9 for protection against cervical gonorrhea
50. The effectiveness of condoms in reducing heterosexual transmission of HIV
51. Adolescents and condom use
52. Condom availability for youth
53. Factors associated with condom use by sexually active male adolescents at risk for sexually transmitted diseases
54. Condom availability in high schools
55. Impact of a high school condom availability program on sexual attitudes and behaviors
56. Partner condom use among adolescent girls with sexually transmitted diseases
57. The male polyurethane condom: A review of current knowledge
58. Breakage and acceptability, of a polyurethane condom: A randomized, controlled study
59. Long-acting injectable contraception with depot medroxyprogesterone acetate
60. Hormonal contraception
61. The contraceptive use of Depo-Provera in US adolescents
62. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception
63. Medroxyprogesterone (Depo-Provera) use in adolescents: Uterine bleeding and blood pressure patterns, patient satisfaction, and continuation rates
64. Use of Depot Medroxyprogesterone acetate contraception in adolescents
65. Depot- medroxyprogesterone acetate and breast cancer
66. Breast disease and hormonal contraception: Resolution of a lasting controversy
67. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives
68. Update on adolescent contraception
69. Depo-Provera: An ideal contraceptive for adolescents?
70. DMPA and bone density loss: An update
71. Sustained-release contraceptives
72. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers
73. Comparison of continuation rates for hormonal contraception among adolescents
74. The significance of bleeding patterns in Norplant implant users
75. Patient satisfaction and side effects with levonorgestrel implant (Norplant) use in adolescents 18 years of age or younger
76. Hormonal treatment for bleeding in users of Norplant implants
77. The intrauterine device
78. Modern IUDs
79. IUD patient selection and practice guidelines
80. A 17-year old mother seeking contraception
81. The IUD: Dispelling the myths and assessing the potential
82. The use of non-hormonal methods of contraception in adolescents
83. Helping teenagers postpone sexual involvement
84. Sexuality education programs for youth: Current state of affairs and strategies for the future
85. Contraception and adolescents
86. Reproductive health: An international perspective